Athira Pharma Inc
NASDAQ:ATHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Athira Pharma Inc
NASDAQ:ATHA
|
US |
|
Brainstorm Cell Therapeutics Inc
OTC:BCLI
|
US |
|
Landis+Gyr Group AG
SIX:LAND
|
CH |
|
Capstone Therapeutics Corp
OTC:CAPS
|
US |
|
White Energy Company Ltd
ASX:WEC
|
AU |
|
T
|
Tekna Holding ASA
OSE:TEKNA
|
NO |
|
Entergy Corp
NYSE:ETR
|
US |
|
A
|
Anglo Pacific Group PLC
TSX:APY
|
UK |
|
Aecon Group Inc
TSX:ARE
|
CA |
|
E
|
EPH European Property Holdings Ltd
SIX:EPH
|
VG |
|
Leonardo DRS Inc
NASDAQ:DRS
|
US |
Intrinsic Value
The intrinsic value for
Athira Pharma Inc (ATHA) under the Base Case is hidden
USD.
Compared with the current market price of 7.66 USD, the stock appears hidden
.
Do our valuations actually work? See backtest results .
ATHA looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if ATHA is one of them.
See where today’s valuation sits in ATHA’s own history and what typically happened over the next 12 months after similar periods.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Athira Pharma Inc.
The intrinsic value for
Athira Pharma Inc (ATHA) under the Base Case is hidden USD.
Compared with the current market price of 7.66 USD, the stock appears hidden.